Carl Zeiss Meditec AG (ETR:AFX)
Germany · Delayed Price · Currency is EUR 33.02
+0.18 (0.55%)
Oct 14, 2026, 5:35 PM CET
Carl Zeiss Meditec AG Ratios and Metrics
Market cap in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| 2,890 | 3,691 | 6,364 | 7,407 | 9,610 | 14,852 | |
Market Cap Growth | -22.78% | -42.01% | -14.09% | -22.92% | -35.29% | 53.75% |
Enterprise Value | 3,457 | 4,273 | 6,503 | 7,567 | 9,741 | 14,981 |
Last Close Price | 33.02 | 41.23 | 68.95 | 79.50 | 102.28 | 157.11 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
PE Ratio | 23.68 | 26.14 | 35.61 | 25.51 | 32.70 | 62.86 |
Forward PE | 23.11 | 20.77 | 27.99 | 25.66 | 34.30 | 57.14 |
PS Ratio | 1.33 | 1.66 | 3.08 | 3.55 | 5.05 | 9.02 |
PB Ratio | 1.37 | 1.74 | 3.09 | 3.41 | 4.73 | 8.85 |
P/TBV Ratio | 5.89 | 4.26 | 8.43 | 4.28 | 6.12 | 11.30 |
P/FCF Ratio | 10.61 | 21.65 | 39.65 | 39.99 | 66.10 | 44.66 |
P/OCF Ratio | 9.63 | 17.59 | 25.73 | 29.53 | 51.07 | 40.95 |
PEG Ratio | 3.53 | 3.29 | 8.51 | 2.88 | 3.71 | 2.17 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
EV/Sales Ratio | 1.58 | 1.92 | 3.15 | 3.62 | 5.12 | 9.10 |
EV/EBITDA Ratio | 14.20 | 15.61 | 30.27 | 20.41 | 23.29 | 38.52 |
EV/EBIT Ratio | 21.88 | 19.14 | 36.70 | 21.68 | 24.49 | 40.45 |
EV/FCF Ratio | 12.69 | 25.07 | 40.52 | 40.86 | 67.00 | 45.05 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Debt / Equity Ratio | 0.28 | 0.25 | 0.27 | 0.07 | 0.06 | 0.07 |
Debt / EBITDA Ratio | 2.39 | 1.79 | 2.30 | 0.39 | 0.29 | 0.30 |
Debt / FCF Ratio | - | 3.14 | 3.45 | 0.84 | 0.88 | 0.37 |
Net Debt / Equity Ratio | 0.26 | 0.24 | 0.26 | 0.07 | 0.06 | 0.07 |
Net Debt / EBITDA Ratio | 2.56 | 1.86 | 2.48 | 0.39 | 0.29 | 0.29 |
Net Debt / FCF Ratio | - | 2.98 | 3.32 | 0.78 | 0.83 | 0.34 |
Asset Turnover | - | 0.66 | 0.64 | 0.71 | 0.73 | 0.75 |
Inventory Turnover | - | 2.04 | 1.85 | 1.96 | 2.32 | 2.37 |
Quick Ratio | - | 1.32 | 1.06 | 2.33 | 2.47 | 2.90 |
Current Ratio | - | 2.35 | 2.13 | 3.40 | 3.32 | 3.58 |
Return on Equity (ROE) | - | 6.80% | 8.52% | 13.89% | 15.96% | 15.19% |
Return on Assets (ROA) | - | 4.11% | 3.45% | 7.45% | 9.53% | 10.50% |
Return on Invested Capital (ROIC) | 4.54% | 6.27% | 5.40% | 11.06% | 14.80% | 15.71% |
Return on Capital Employed (ROCE) | - | 7.80% | 6.30% | 14.10% | 17.40% | 19.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Earnings Yield | 4.20% | 3.83% | 2.81% | 3.92% | 3.06% | 1.59% |
FCF Yield | 9.43% | 4.62% | 2.52% | 2.50% | 1.51% | 2.24% |
Dividend Yield | 1.67% | 1.31% | 0.83% | 1.33% | 1.02% | 0.54% |
Payout Ratio | - | 37.19% | 54.95% | 33.88% | 27.39% | 18.93% |
Buyback Yield / Dilution | 0.45% | 1.48% | 0.66% | - | - | - |
Total Shareholder Return | 2.12% | 2.79% | 1.48% | 1.33% | 1.02% | 0.54% |